The potential of chondroitin sulfate as a therapeutic agent

Connective Tissue Research

Volumn 49, Issue 3-4, 2008, Pages 289-292

  Lamari, Fotini N ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Chondroitin Sulfate; Formulation; Osteoarthritis; Pharmacokinetics; Structure

Indexed keywords

CELECOXIB; CHONDROITIN SULFATE; GLUCOSAMINE; PLACEBO;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; HUMAN; NONHUMAN; OSTEOARTHRITIS; QUALITY CONTROL; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; SYMPTOM;

ANIMALS; CHONDROITIN SULFATES; CLINICAL TRIALS AS TOPIC; HUMANS; OSTEOARTHRITIS;

EID: 48549085535     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200802148314     Document Type: Article

References (37)

1. Iozzo, R. V. (1997) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. 32:2, pp. 141-174.
2. Trowbridge, J. M. and Gallo, R. L. (2002) Dermatan sulfate: New functions from an old glycosaminoglycan. 12:9, pp. 117R-25R.
3. Hathcock, J. N. and Shao, A. (2007) Risk assessment for glucosamine and chondroitin sulfate. 47:1, pp. 78-83.
4. Lamari, F. N. and Karamanos, N. K. (2006) Structure of chondroitin sulfate. pp. 33-48. Academic Press, San Diego, CA
5. Vynios, D. H., Karamanos, N. K. and Tsiganos, C. P. (2002) Advances in analysis of glycosaminoglycans: Its application for the assessment of physiological and pathological states of connective tissues. 781:1, pp. 21-38.
6. Takagaki, K., Munakata, H., Kakizaki, I., Iwafune, M., Itabashi, T. and Endo, M. (2002) Domain structure of chondroitin sulfate E octasaccharides binding to type V collagen. 277:11, pp. 8882-8889.
7. Maimone, M. M. and Tollefsen, D. M. (1991) Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. 266:22, p. 14830.
8. Desaire, H., Sirich, T. L. and Leary, J. A. (2001) Evidence of block and randomly sequenced chondroitin polysaccharides: Sequential enzymatic digestion and quantification using ion trap tandem mass spectrometry. 73:15, pp. 3513-3520.
9. Mitropoulou, T. N., Lamari, F., Syrokou, A., Hjerpe, A. and Karamanos, N. K. (2001) Identification of oligomeric domains within dermatan sulfate chains using differential enzymic treatments, derivatization with 2-aminoacridone and capillary electrophoresis. 22:12, pp. 2458-2463.
10. Adebowale, A. O., Cox, D. S., Liang, Z. and Eddington, N. D. (2000) Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials. 3:1, pp. 37-44.
11. Sim, J. S., Jun, G., Toida, T., Cho, S. Y., Choi, D. W., Chang, S. Y., Linhardt, R. J. and Kim, Y. S. (2005) Quantitative analysis of chondroitin sulphate in raw materials, ophthalmic solutions, soft capsules and liquid preparations. 818:2, pp. 133-139.
12. Barnhill, J. G., Fye, C. L., Williams, D. W., Reda, D. J., Harris, C. L. and Clegg, D. O. (2006) Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. 46, pp. 14-24.
13. Saad, O. M., Myers, R. A., Castleton, D. L. and Leary, J. A. (2005) Analysis of hyaluronan content in chondroitin sulfate preparations by using selective enzymatic digestion and electrospray ionization mass spectrometry. 344, pp. 232-239.
14. Malavaki, C. J., Asimakopoulou, A. P., Lamari, F. N., Theocharis, A. D., Tzanakakis, G. and Karamanos, N. K. (2007) Capillary electrophoresis for the quality control of chondroitin sulfates in raw materials and formulations. 374, pp. 213-220.
15. Lamari, F. N., Theocharis, A. D., Asimakopoulou, A. P., Malavaki, C. J. and Karamanos, N. K. (2006) Metabolism and biochemical/physiological roles of chondroitin sulfates: Analysis of endogenous and supplemental chondroitin sulfates in blood circulation. 20:6, pp. 539-550.
16. Adebowale, A., Du, J., Liang, Z., Leslie, J. L. and Eddington, N. D. (2002) The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. 23:6, pp. 217-225.
17. Volpi, N. (2002) Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. 10:10, pp. 768-777.
18. Volpi, N. (2003) Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers. 11:6, pp. 433-441.
19. Palmieri, L., Conte, A., Giovannini, L., Lualdi, P. and Ronca, G. (1990) Metabolic fate of exogenous chondroitin sulfate in the experimental animal. 40:3, pp. 319-323.
20. Ronca, F., Palmieri, L., Panicucci, P. and Ronca, G. (1998) Anti-inflammatory activity of chondroitin sulfate. 6, pp. 14-21.
21. Pecly, I. M. D., Melo-Fihlo, N. M. and Mourao, P. A. S. (2006) Effects of molecular size and chemical structure on renal and hepatic removal of exogenously administered chondroitin sulfate in rats. 1760, pp. 865-876.
22. Harris, E. N., Kyosseva, S. V., Weigel, J. A. and Weigel, P. H. (2007) Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE). 282:5, pp. 2785-2795.
23. Bruyere, O. and Reginster, J. -Y. (2007) Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. 24:7, pp. 573-580.
24. McAlindon, T. E., LaValley, M. P., Gulin, J. P. and Felson, D. T. (2000) Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and metaanalysis. 283, pp. 1469-1475.
25. Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C.O. 3rd, Weisman, M. H., Jackson, C. G., Lane, N. E., Cush, J. J., Moreland, L. W., Schumacher, H.R. Jr., Oddis, C. V., Wolfe, F., Molitor, J. A., Yocum, D. E., Schnitzer, T. J., Furst, D. E., Sawitzke, A. D., Shi, H., Brandt, K. D., Moskowitz, R. W. and Williams, H. J. (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. 354:8, pp. 795-808.
26. Messier, S. P., Mihalko, S., Loeser, R. F., Legault, C., Jolla, J., Pfruender, J., Prosser, B., Adrian, A. and Williamson, J. D. (2007) Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: A preliminary study.
27. Mazieres, B., Hucher, M., Zaim, M. and Garnero, P. (2007) Effect of chondroitin sulphate in symptomatic knee osteoarthritis: A multicentre, randomised, double-blind, placebo-controlled study. 66:5, pp. 639-645.
28. Bjordal, J. M., Klovning, A., Ljunggren, A. E. and Slordal, L. (2007) Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. 11, pp. 125-138.
29. Reichenbach, S., Sterchi, R., Scherer, M., Trelle, S., Burgi, E., Burgi, U., Dieppe, P. A. and Juni, P. (2007) Meta-analysis: Chondroitin for osteoarthritis of the knee or hip. 146, pp. 580-590.
30. Michel, B. A., Stucki, G., Frey, D., De Vathaire, F., Vignon, E., Bruehlmann, P. and Uebelhart, D. (2005) Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: A randomized, controlled trial. 52:3, p. 7790.
31. Verges, J., Montell, E., Herrero, M., Perna, C., Cuevas, J., Perez, M. and Moller, I. (2005) Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: A serendipitous finding. 11:1, p. 31.
32. Theoharides, T. C. and Sant, G. R. (2005) A pilot open label study of Cystoprotek in interstitial cystitis. 18:1, pp. 183-188.
33. Steinhoff, G., Ittah, B. and Rowan, S. (2002) The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis.9:1, pp. 1454-1458.
34. Fioravanti, A. and Collodel, G. (2006) Structure of chondroitin sulfate. pp. 449-465. Academic Press, San Diego, CA
35. Campo, G. M., Avenoso, A., Campo, S., Ferlazzo, A. M. and Calatroni, A. (2006) Antioxidant activity of chondroitin sulfate. pp. 417-431. Academic Press, San Diego, CA
36. Toida, T., Sakai, S., Akiyama, H. and Linhardt, R. J. (2006) Immunological activity of chondroitin sulfate. pp. 403-415. Academic Press, San Diego, CA
37. Legendre, F., Bauge, C., Roche, R., Saurel, A. S. and Pujol, J. P. (2007) Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes-study in hypoxic alginate bead cultures. 16:1, pp. 105-114.